MetLife (MET)
MetLife on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as life insurance.
10.8M
Short interest
settlement 2026-10-15
3.3
Days to cover
-0.1 days vs prior
46.1%
Short share of volume
2026-10-28
2
Fails to deliver
settlement 2026-09-28
Wed 4 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in MET is 10,759,153 shares, down 1,526,257 shares over the last month. Over the last 48 readings it ranged from 5,000,757 shares (15 November 2024) to 15,879,586 shares (15 June 2026). At the reported average volume of 3.3M shares a day that is 3.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/met" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 10,759,153 | -4.0% | 3,276,459 | 3.28 |
| 2026-09-30 | 11,201,864 | -8.8% | 3,366,439 | 3.33 |
| 2026-09-15 | 12,285,410 | +3.6% | 2,764,823 | 4.44 |
| 2026-08-31 | 11,852,557 | +4.8% | 2,935,767 | 4.04 |
| 2026-08-14 | 11,308,929 | +0.2% | 3,466,395 | 3.26 |
| 2026-07-31 | 11,289,925 | -11.6% | 4,413,183 | 2.56 |
| 2026-07-15 | 12,774,912 | -10.6% | 3,053,738 | 4.18 |
| 2026-06-30 | 14,290,276 | -10.0% | 4,578,726 | 3.12 |
| 2026-06-15 | 15,879,586 | +13.5% | 3,463,132 | 4.59 |
| 2026-05-29 | 13,989,068 | +15.5% | 3,744,263 | 3.74 |
| 2026-05-15 | 12,109,631 | -2.1% | 3,183,219 | 3.80 |
| 2026-04-30 | 12,367,743 | -1.4% | 3,221,329 | 3.84 |
| 2026-04-15 | 12,543,207 | -11.2% | 3,359,949 | 3.73 |
| 2026-03-31 | 14,116,523 | +9.8% | 3,845,983 | 3.67 |
| 2026-03-13 | 12,852,689 | +15.6% | 4,342,125 | 2.96 |
| 2026-02-27 | 11,116,957 | +8.0% | 4,257,742 | 2.61 |
| 2026-02-13 | 10,295,795 | -5.6% | 4,731,501 | 2.18 |
| 2026-01-30 | 10,901,829 | +9.3% | 3,685,323 | 2.96 |
| 2026-01-15 | 9,975,013 | +16.6% | 3,354,704 | 2.97 |
| 2025-12-31 | 8,553,459 | +3.7% | 3,228,118 | 2.65 |
| 2025-12-15 | 8,247,239 | -11.4% | 3,439,610 | 2.40 |
| 2025-11-28 | 9,306,296 | +21.1% | 3,403,728 | 2.73 |
| 2025-11-14 | 7,686,132 | -1.1% | 4,565,315 | 1.68 |
| 2025-10-31 | 7,771,658 | -18.3% | 3,002,858 | 2.59 |
| 2025-10-15 | 9,511,270 | -12.5% | 2,763,235 | 3.44 |
| 2025-09-30 | 10,869,901 | +10.2% | 4,454,515 | 2.44 |
| 2025-09-15 | 9,863,576 | +8.6% | 2,919,480 | 3.38 |
| 2025-08-29 | 9,083,033 | +4.5% | 2,639,618 | 3.44 |
| 2025-08-15 | 8,694,057 | +16.8% | 3,957,360 | 2.20 |
| 2025-07-31 | 7,444,390 | -7.8% | 2,992,608 | 2.49 |
| 2025-07-15 | 8,071,758 | +14.3% | 2,531,201 | 3.19 |
| 2025-06-30 | 7,061,686 | -10.9% | 3,311,866 | 2.13 |
| 2025-06-13 | 7,930,380 | +6.8% | 2,354,126 | 3.37 |
| 2025-05-30 | 7,421,995 | +6.5% | 2,829,739 | 2.62 |
| 2025-05-15 | 6,970,540 | +2.0% | 3,055,963 | 2.28 |
| 2025-04-30 | 6,832,756 | +6.0% | 3,337,969 | 2.05 |
| 2025-04-15 | 6,446,179 | -9.7% | 5,357,233 | 1.20 |
| 2025-03-31 | 7,139,843 | +11.2% | 3,675,777 | 1.94 |
| 2025-03-14 | 6,419,816 | -12.7% | 3,522,773 | 1.82 |
| 2025-02-28 | 7,356,999 | -3.3% | 3,289,211 | 2.24 |
| 2025-02-14 | 7,607,237 | +11.8% | 3,987,359 | 1.91 |
| 2025-01-31 | 6,801,785 | -8.0% | 3,592,108 | 1.89 |
| 2025-01-15 | 7,396,147 | +17.7% | 3,400,159 | 2.18 |
| 2024-12-31 | 6,284,173 | -3.3% | 3,113,476 | 2.02 |
| 2024-12-13 | 6,499,718 | +4.8% | 3,876,093 | 1.68 |
| 2024-11-29 | 6,201,590 | +24.0% | 2,843,067 | 2.18 |
| 2024-11-15 | 5,000,757 | -13.9% | 3,788,083 | 1.32 |
| 2024-10-31 | 5,807,356 | -31.1% | 2,837,854 | 2.05 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of MET volume is 46.1%, down 18.1 points over the last five sessions. Over the last 30 readings it ranged from 30.3% (14 October 2026) to 74.6% (18 September 2026). The latest reading is 8.0 points below the 30-session average of 54.1%, on 612K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 282K | 612K | 46.1% | 137 |
| 2026-10-27 | 365K | 590K | 61.9% | 300 |
| 2026-10-26 | 338K | 1.1M | 31.4% | 31 |
| 2026-10-23 | 772K | 1.9M | 40.3% | 20,181 |
| 2026-10-22 | 377K | 728K | 51.8% | 157 |
| 2026-10-21 | 507K | 789K | 64.2% | 233 |
| 2026-10-20 | 399K | 606K | 65.9% | 62 |
| 2026-10-19 | 329K | 554K | 59.5% | 3,304 |
| 2026-10-16 | 509K | 998K | 51.1% | 21 |
| 2026-10-15 | 365K | 761K | 48.0% | 521 |
| 2026-10-14 | 348K | 1.1M | 30.3% | 8 |
| 2026-10-13 | 358K | 906K | 39.5% | 16 |
| 2026-10-12 | 323K | 564K | 57.3% | 13 |
| 2026-10-09 | 528K | 831K | 63.6% | 0 |
| 2026-10-08 | 607K | 973K | 62.4% | 45 |
| 2026-10-07 | 503K | 750K | 67.1% | 18 |
| 2026-10-06 | 937K | 1.7M | 56.0% | 858 |
| 2026-10-05 | 1.0M | 2.1M | 48.1% | 153 |
| 2026-10-02 | 370K | 758K | 48.8% | 5,416 |
| 2026-10-01 | 438K | 972K | 45.0% | 1,596 |
| 2026-09-30 | 386K | 739K | 52.3% | 165 |
| 2026-09-29 | 496K | 974K | 51.0% | 592 |
| 2026-09-28 | 579K | 954K | 60.7% | 21,846 |
| 2026-09-25 | 748K | 1.1M | 68.4% | 0 |
| 2026-09-24 | 591K | 993K | 59.6% | 4,333 |
| 2026-09-23 | 666K | 1.1M | 58.4% | 1,724 |
| 2026-09-22 | 323K | 735K | 44.0% | 2 |
| 2026-09-21 | 279K | 536K | 52.1% | 10 |
| 2026-09-18 | 638K | 855K | 74.6% | 0 |
| 2026-09-17 | 528K | 808K | 65.3% | 5 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 28 September 2026, the fails-to-deliver balance in MET is 2 shares, down 153,788 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (31 August 2026) to 153,790 shares (22 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-28 | 2 | $97.70 | $195 |
| 2026-09-22 | 153,790 | $96.64 | $14.9M |
| 2026-09-21 | 212 | $97.04 | $21K |
| 2026-09-17 | 72,006 | $97.23 | $7.0M |
| 2026-09-11 | 45 | $96.78 | $4K |
| 2026-09-09 | 101,283 | $95.50 | $9.7M |
| 2026-09-01 | 108 | $95.17 | $10K |
| 2026-08-31 | 1 | $96.51 | $97 |
| 2026-08-28 | 2,717 | $96.25 | $262K |
| 2026-08-19 | 24,917 | $96.73 | $2.4M |
| 2026-08-13 | 44 | $96.66 | $4K |
| 2026-08-07 | 2 | $99.95 | $200 |
| 2026-08-06 | 66,318 | $96.26 | $6.4M |
| 2026-08-04 | 7,926 | $96.31 | $763K |
| 2026-08-03 | 28 | $96.13 | $3K |
| 2026-07-27 | 31 | $94.83 | $3K |
| 2026-07-20 | 2,646 | $94.00 | $249K |
| 2026-07-06 | 34 | $90.06 | $3K |
| 2026-07-02 | 375 | $87.20 | $33K |
| 2026-07-01 | 14,981 | $84.61 | $1.3M |
| 2026-06-30 | 35 | $85.99 | $3K |
| 2026-06-29 | 56 | $85.95 | $5K |
| 2026-06-25 | 1,591 | $84.60 | $135K |
| 2026-06-22 | 406 | $85.58 | $35K |
| 2026-06-15 | 8,323 | $88.84 | $739K |
| 2026-06-11 | 48,058 | $86.13 | $4.1M |
| 2026-06-04 | 11,150 | $80.96 | $903K |
| 2026-06-03 | 50 | $82.82 | $4K |
| 2026-06-01 | 13,351 | $82.69 | $1.1M |
| 2026-05-28 | 13,567 | $83.20 | $1.1M |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for MET in the last 90 days. The most recent filings are listed below. Latest filing: Mumenthaler Christian Stephane (Director) on 2026-10-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Mumenthaler Christian Stephane | Director | Grant | 544 | $94.35 | $51K | 4K |
| 2026-10-01 | Seitz Michelle | Director | Grant | 544 | $0.00 | $0 | 2K |
| 2026-10-01 | WEINBERGER MARK A | Director | Grant | 544 | $0.00 | $0 | 20K |
| 2026-10-01 | MCKENZIE DIANA | Director | Grant | 544 | $94.35 | $51K | 26K |
| 2026-10-01 | Kennard William E | Director | Grant | 544 | $94.35 | $51K | 48K |
| 2026-10-01 | Johnson Jeh C. | Director | Grant | 544 | $94.35 | $51K | 10K |
| 2026-10-01 | Hay Laura J | Director | Grant | 544 | $94.35 | $51K | 7K |
| 2026-10-01 | Harris Carla A | Director | Grant | 544 | $94.35 | $51K | 12K |
| 2026-10-01 | HUBBARD ROBERT GLENN | Director | Grant | 941 | $94.35 | $89K | 109K |
| 2026-10-01 | Glaser Daniel S | Director | Grant | 544 | $94.35 | $51K | 3K |
| 2026-09-08 | Mumenthaler Christian Stephane | Director | Grant | 21 | $95.50 | $2K | 3K |
| 2026-09-08 | TADROS RAMY | President, U.S. Business | Grant | 115 | $95.50 | $11K | 213K |
| 2026-09-08 | MCKENZIE DIANA | Director | Grant | 157 | $95.50 | $15K | 25K |
| 2026-09-08 | Kennard William E | Director | Grant | 294 | $95.50 | $28K | 48K |
| 2026-09-08 | Johnson Jeh C. | Director | Grant | 59 | $95.50 | $6K | 10K |
| 2026-09-08 | Hay Laura J | Director | Grant | 39 | $95.50 | $4K | 6K |
| 2026-09-08 | Harris Carla A | Director | Grant | 42 | $95.50 | $4K | 11K |
| 2026-09-08 | HUBBARD ROBERT GLENN | Director | Grant | 618 | $95.50 | $59K | 108K |
| 2026-09-08 | Glaser Daniel S | Director | Grant | 10 | $95.50 | $955 | 3K |
| 2026-08-31 | PAPPAS BILL | EVP, Global Tech. & Ops. | Tax withholding | 4K | $95.17 | $384K | 80K |
| 2026-08-31 | TADROS RAMY | President, U.S. Business | Tax withholding | 4K | $95.17 | $416K | 213K |
| 2026-08-31 | McCallion John D. | EVP & Chief Financial Officer | Tax withholding | 6K | $95.17 | $576K | 269K |
| 2026-08-31 | DEBEL MARLENE | EVP & Chief Risk Officer | Tax withholding | 4K | $95.17 | $384K | 150K |
| 2026-06-16 | WEINBERGER MARK A | Director | Grant | 587 | $0.00 | $0 | 19K |
| 2026-06-16 | Glaser Daniel S | Director | Grant | 587 | $87.40 | $51K | 3K |
| 2026-06-16 | Seitz Michelle | Director | Grant | 587 | $0.00 | $0 | 2K |
| 2026-06-16 | Harris Carla A | Director | Grant | 587 | $87.40 | $51K | 11K |
| 2026-06-16 | HUBBARD ROBERT GLENN | Director | Grant | 1K | $87.40 | $89K | 108K |
| 2026-06-16 | Hay Laura J | Director | Grant | 587 | $87.40 | $51K | 6K |
| 2026-06-16 | MCKENZIE DIANA | Director | Grant | 587 | $87.40 | $51K | 25K |
| 2026-06-16 | Johnson Jeh C. | Director | Grant | 587 | $87.40 | $51K | 9K |
| 2026-06-16 | Kennard William E | Director | Grant | 587 | $87.40 | $51K | 47K |
| 2026-06-16 | Mumenthaler Christian Stephane | Director | Grant | 587 | $87.40 | $51K | 3K |
| 2026-06-09 | Mumenthaler Christian Stephane | Director | Grant | 20 | $85.57 | $2K | 3K |
| 2026-06-09 | TADROS RAMY | President, U.S. Business | Grant | 127 | $85.57 | $11K | 217K |
| 2026-06-09 | MCKENZIE DIANA | Director | Grant | 169 | $85.57 | $14K | 25K |
| 2026-06-09 | Kennard William E | Director | Grant | 322 | $85.57 | $28K | 47K |
| 2026-06-09 | Johnson Jeh C. | Director | Grant | 61 | $85.57 | $5K | 9K |
| 2026-06-09 | Hay Laura J | Director | Grant | 39 | $85.57 | $3K | 6K |
| 2026-06-09 | Harris Carla A | Director | Grant | 42 | $85.57 | $4K | 11K |
| 2026-06-09 | HUBBARD ROBERT GLENN | Director | Grant | 678 | $85.57 | $58K | 107K |
| 2026-06-09 | Glaser Daniel S | Director | Grant | 7 | $85.57 | $599 | 2K |
| 2026-06-01 | DEBEL MARLENE | EVP & Chief Risk Officer | Sell | 21K | $81.59 | $1.7M | 154K |
| 2026-06-01 | DEBEL MARLENE | EVP & Chief Risk Officer | Exercise or conversion | 11K | $45.50 | $487K | 176K |
| 2026-06-01 | DEBEL MARLENE | EVP & Chief Risk Officer | Exercise or conversion | 11K | $46.85 | $497K | 165K |
| 2026-04-30 | O'Neill Adrienne Karen | EVP & Chief Accounting Officer | Grant | 12K | price not stated in the filing | not stated | 27K |
| 2026-04-01 | Mumenthaler Christian Stephane | Director | Grant | 721 | $71.17 | $51K | 3K |
| 2026-04-01 | Seitz Michelle | Director | Grant | 721 | $0.00 | $0 | 994 |
| 2026-04-01 | WEINBERGER MARK A | Director | Grant | 721 | $0.00 | $0 | 19K |
| 2026-04-01 | MORRISON DENISE M | Director | Grant | 721 | $0.00 | $0 | 35K |
| 2026-04-01 | MCKENZIE DIANA | Director | Grant | 721 | $71.17 | $51K | 24K |
| 2026-04-01 | Kennard William E | Director | Grant | 721 | $71.17 | $51K | 47K |
| 2026-04-01 | Johnson Jeh C. | Director | Grant | 721 | $71.17 | $51K | 9K |
| 2026-04-01 | Hay Laura J | Director | Grant | 721 | $71.17 | $51K | 6K |
| 2026-04-01 | Harris Carla A | Director | Grant | 721 | $71.17 | $51K | 10K |
| 2026-04-01 | HUBBARD ROBERT GLENN | Director | Grant | 1K | $71.17 | $89K | 106K |
| 2026-04-01 | Glaser Daniel S | Director | Grant | 721 | $71.17 | $51K | 2K |
| 2026-04-01 | GUTIERREZ CARLOS M | Director | Grant | 721 | $0.00 | $0 | 26K |
| 2026-03-10 | Mumenthaler Christian Stephane | Director | Grant | 17 | $70.60 | $1K | 2K |
| 2026-03-10 | MCKENZIE DIANA | Director | Grant | 189 | $70.60 | $13K | 24K |
| 2026-03-10 | Kennard William E | Director | Grant | 365 | $70.60 | $26K | 46K |
| 2026-03-10 | Johnson Jeh C. | Director | Grant | 65 | $70.60 | $5K | 8K |
| 2026-03-10 | Hay Laura J | Director | Grant | 40 | $70.60 | $3K | 5K |
| 2026-03-10 | Harris Carla A | Director | Grant | 43 | $70.60 | $3K | 10K |
| 2026-03-10 | HUBBARD ROBERT GLENN | Director | Grant | 771 | $70.60 | $54K | 105K |
| 2026-03-02 | Sibblies Shurawl | EVP & Chief HR Officer | Tax withholding | 220 | $73.24 | $16K | 28K |
| 2026-03-02 | PAPPAS BILL | EVP, Global Tech. & Ops. | Tax withholding | 6K | $73.24 | $439K | 84K |
| 2026-03-02 | TADROS RAMY | President, U.S. Business | Tax withholding | 5K | $73.24 | $378K | 217K |
| 2026-03-02 | McCallion John D. | EVP & Chief Financial Officer | Tax withholding | 7K | $73.24 | $512K | 275K |
| 2026-03-02 | Khalaf Michel | President & CEO | Tax withholding | 22K | $73.24 | $1.6M | 698K |
| 2026-03-02 | DEBEL MARLENE | EVP & Chief Risk Officer | Tax withholding | 4K | $73.24 | $303K | 154K |
| 2026-03-02 | Curtis Monica M | EVP & Chief Legal Officer | Tax withholding | 953 | $73.24 | $70K | 18K |
| 2026-02-24 | McCallion John D. | EVP & Chief Financial Officer | Grant | 27K | price not stated in the filing | not stated | 296K |
| 2026-02-24 | McCallion John D. | EVP & Chief Financial Officer | Grant | 24K | price not stated in the filing | not stated | 269K |
| 2026-02-24 | McCallion John D. | EVP & Chief Financial Officer | Tax withholding | 14K | $75.34 | $1.0M | 282K |
| 2026-02-24 | Khalaf Michel | President & CEO | Grant | 69K | price not stated in the filing | not stated | 682K |
| 2026-02-24 | Khalaf Michel | President & CEO | Tax withholding | 43K | $75.34 | $3.2M | 720K |
| 2026-02-24 | Khalaf Michel | President & CEO | Grant | 81K | price not stated in the filing | not stated | 763K |
| 2026-02-24 | Sibblies Shurawl | EVP & Chief HR Officer | Grant | 6K | price not stated in the filing | not stated | 28K |
| 2026-02-24 | O'Neill Adrienne Karen | EVP & Chief Accounting Officer | Grant | 3K | price not stated in the filing | not stated | 15K |
| 2026-02-24 | PAPPAS BILL | EVP, Global Tech. & Ops. | Grant | 21K | price not stated in the filing | not stated | 79K |
| 2026-02-24 | PAPPAS BILL | EVP, Global Tech. & Ops. | Grant | 23K | price not stated in the filing | not stated | 101K |
| 2026-02-24 | PAPPAS BILL | EVP, Global Tech. & Ops. | Tax withholding | 12K | $75.34 | $880K | 90K |
| 2026-02-24 | Curtis Monica M | EVP & Chief Legal Officer | Grant | 8K | price not stated in the filing | not stated | 18K |
| 2026-02-24 | Curtis Monica M | EVP & Chief Legal Officer | Grant | 420 | price not stated in the filing | not stated | 19K |
| 2026-02-24 | Curtis Monica M | EVP & Chief Legal Officer | Tax withholding | 237 | $75.34 | $18K | 19K |
| 2026-02-24 | DEBEL MARLENE | EVP & Chief Risk Officer | Grant | 15K | price not stated in the filing | not stated | 164K |
| 2026-02-24 | DEBEL MARLENE | EVP & Chief Risk Officer | Grant | 15K | price not stated in the filing | not stated | 149K |
| 2026-02-24 | DEBEL MARLENE | EVP & Chief Risk Officer | Tax withholding | 6K | $75.34 | $424K | 159K |
| 2026-02-24 | TADROS RAMY | President, U.S. Business | Grant | 23K | price not stated in the filing | not stated | 224K |
| 2026-02-24 | TADROS RAMY | President, U.S. Business | Grant | 20K | price not stated in the filing | not stated | 201K |
| 2026-02-24 | TADROS RAMY | President, U.S. Business | Tax withholding | 2K | $75.34 | $173K | 222K |
| 2026-02-24 | Glaser Daniel S | Director | Grant | 273 | $75.34 | $21K | 1K |
| 2026-02-24 | Seitz Michelle | Director | Grant | 273 | $0.00 | $0 | 273 |
| 2026-02-24 | Glaser Daniel S | Director | Grant | 273 | $75.34 | $21K | 2K |
| 2026-01-02 | Mumenthaler Christian Stephane | Director | Grant | 639 | $80.32 | $51K | 2K |
| 2026-01-02 | WEINBERGER MARK A | Director | Grant | 639 | $0.00 | $0 | 18K |
| 2026-01-02 | MORRISON DENISE M | Director | Grant | 639 | $0.00 | $0 | 34K |
| 2026-01-02 | MCKENZIE DIANA | Director | Grant | 639 | $80.32 | $51K | 24K |
| 2026-01-02 | Kennard William E | Director | Grant | 639 | $80.32 | $51K | 45K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON22 Form 144 notices on file for MET worth $2.1M at the prices reported; 0 in the last 90 days worth $0. Latest: DEBEL MARLENE filed on 2026-06-01 to sell 21,312 shares ($1.7M) from 2026-06-01.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-06-01 | DEBEL MARLENEOfficer | 21K | $1.7M | 0.003% | 2026-06-01 | Fidelity Brokerage Services LLC |
| 2026-04-02 | Separate Account 149Affiliate | 121 | $9K | 0.000% | 2026-04-02 | Barclays |
| 2026-03-20 | Metlife 401(k) Plan Large Cap Equity IndexAffiliate | 120 | $8K | 0.000% | 2026-03-20 | Barclays |
| 2026-03-20 | MetLife Separate Account SPIAffiliate | 100 | $7K | 0.000% | 2026-03-20 | Barclays |
| 2026-03-20 | Separate Account IIAffiliate | 145 | $10K | 0.000% | 2026-03-20 | Barclays |
| 2026-03-20 | SA 149- Metropolitan Tower Life InsuranceAffiliate | 8 | $549 | 0.000% | 2026-03-20 | Barclays |
| 2026-03-02 | Metlife 401(k) Plan Large cap equity IndexAffiliate discretionary manager | 725 | $52K | 0.000% | 2026-03-02 | Wells Fargo |
| 2026-01-09 | MetLife Separate Account SPIAffiliate | 562 | $45K | 0.000% | 2026-01-09 | Bernstein Institutional Services LLC |
| 2025-12-19 | Russell 1000 Value MetLife 401k PlanAffiliate discretionary manager | 68 | $6K | 0.000% | 2025-12-19 | Bernstein Institutional Services LLC |
| 2025-12-19 | Metlife 401(k) Plan Large cap equity IndexAffiliate discretionary manager | 359 | $29K | 0.000% | 2025-12-19 | Bernstein Institutional Services LLC |
| 2025-12-19 | Separate Account IIAffiliate | 38 | $3K | 0.000% | 2025-12-19 | Bernstein Institutional Services LLC |
| 2025-12-19 | MetLife Separate Account SPIAffiliate | 137 | $11K | 0.000% | 2025-12-19 | Bernstein Institutional Services LLC |
| 2025-12-19 | Separate Account 149Affiliate | 10 | $817 | 0.000% | 2025-12-19 | Bernstein Institutional Services LLC |
| 2025-12-17 | Separate Account IIAffiliate | 231 | $19K | 0.000% | 2025-12-17 | Barclays |
| 2025-12-01 | MetLife Separate Account SPIAffiliate | 335 | $26K | 0.000% | 2025-12-01 | Wells Fargo |
| 2025-11-20 | Separate Account 149- MetropolitanTower Life Ins CoAffiliate | 30 | $2K | 100.000% | 2025-11-20 | Barclays |
| 2025-10-29 | Russell 1000 Value MetLife 401k PlanAffiliate discretionary manager | 196 | $15K | 0.000% | 2025-10-29 | Barclays |
| 2025-10-01 | Metlife 401(k) Plan Large cap equity IndexAffiliate discretionary manager | 333 | $27K | 0.000% | 2025-10-01 | Wells Fargo |
| 2025-09-19 | Metlife 401(k) Plan Large cap equity IndexAffiliate discretionary manager | 269 | $21K | 0.000% | 2025-09-19 | Bernstein Institutional Services LLC |
| 2025-09-19 | MetLife Separate Account SPIAffiliate | 221 | $17K | 0.000% | 2025-09-19 | Bernstein Institutional Services LLC |
| 2025-09-19 | Separate Account 149Affiliate | 17 | $1K | 0.000% | 2025-09-19 | Bernstein Institutional Services LLC |
| 2025-09-19 | Separate Account IIAffiliate | 64 | $5K | 0.000% | 2025-09-19 | Bernstein Institutional Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of MET in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is Board of Directors of MetLife, Inc., as an entity at 16.1% of the class (102,098,469 shares), filed 2026-08-06 for an event on 2026-08-06.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-06 | 13D/Ano. 106 | Board of Directors of MetLife, Inc., as an entityinsurance company | 102.1M | 16.1% | 2026-08-06 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 41.5M | 6.4% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 11 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding MET at their latest 13F. JSON7 of the 30 tracked managers held MET at their latest 13F, $511.7M in total at quarter-end prices. AQR Capital Management is the largest at $348.8M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 4.1M | $348.8M | 0.12% | +477K |
| Citadel Advisors | 2026-06-30 | 872K | $73.8M | 0.01% | -260K |
| Bridgewater Associates | 2026-06-30 | 622K | $52.6M | 0.22% | -5K |
| Millennium Management | 2026-06-30 | 188K | $15.9M | 0.01% | -921K |
| D. E. Shaw & Co. | 2026-06-30 | 184K | $15.6M | 0.01% | +118K |
| Two Sigma Investments | 2026-06-30 | 54K | $4.5M | 0.00% | -988 |
| Fisher Asset Management | 2026-06-30 | 5K | $463K | 0.00% | +2K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) MetLife reported revenue of $724.0M, up 19.9% from the same quarter a year earlier, and net income of $736.0M (1.09 diluted EPS). In FY 2025 it generated $17.09B of operating cash flow and spent $2.88B on buybacks and $1.51B on dividends.
- Cash
- $19.30B
- Equity
- $27.44B
- Total assets
- $759.37B
- Shares outstanding
- 635,476,927
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $724.0M | $736.0M | 101.7% | 1.09 |
| Q1 FY 2026 | 2026-03-31 | $734.0M | $1.19B | 161.4% | 1.74 |
| Q4 FY 2025derived | 2025-12-31 | $600.0M | $809.0M | 134.8% | n/a |
| Q3 FY 2025 | 2025-09-30 | $621.0M | $896.0M | 144.3% | 1.22 |
| Q2 FY 2025 | 2025-06-30 | $604.0M | $729.0M | 120.7% | 1.03 |
| Q1 FY 2025 | 2025-03-31 | $611.0M | $945.0M | 154.7% | 1.28 |
| Q4 FY 2024derived | 2024-12-31 | $556.0M | $1.27B | 228.6% | n/a |
| Q3 FY 2024 | 2024-09-30 | $554.0M | $1.34B | 242.2% | 1.81 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.44B | $3.38B | $17.09B | n/a | $2.88B | $1.51B |
| FY 2024 | 2024-12-31 | $2.25B | $4.43B | $14.60B | n/a | $3.21B | $1.53B |
| FY 2023 | 2023-12-31 | $2.23B | $1.58B | $13.72B | n/a | $3.10B | $1.57B |
| FY 2022 | 2022-12-31 | $2.11B | $5.28B | $13.04B | n/a | $3.33B | $1.60B |
| FY 2021 | 2021-12-31 | $2.07B | $6.86B | $12.35B | n/a | $4.30B | $1.65B |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
MetLife in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows MetLife (MET), SEC CIK 1099219, listed on NYSE, classified by the SEC as life insurance. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-28.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-06-01.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-06.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 1099219Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as life insurance
Other company pages
Datasets
Frequently Asked Questions
How much of MET is sold short?
10,759,153 shares were held short at the 2026-10-15 settlement, 3.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is MET's daily short volume?
On 2026-10-28, 282,345 of the 612,045 MET shares reported to FINRA were sold short, 46.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does MET have fails to deliver?
The SEC's latest file shows 2 MET shares failed to deliver at settlement 2026-09-28. Fails are reported per settlement date and published twice a month with a lag.
Are MET insiders buying or selling?
No open-market insider trades were reported for MET in the last 90 days. The most recent filings are listed below. Latest filing: Mumenthaler Christian Stephane (Director) on 2026-10-01.
Have MET insiders filed to sell?
22 Form 144 notices on file for MET worth $2.1M at the prices reported; 0 in the last 90 days worth $0. Latest: DEBEL MARLENE filed on 2026-06-01 to sell 21,312 shares ($1.7M) from 2026-06-01.
Who owns 5% or more of MET?
2 holders report 5% or more of MET in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is Board of Directors of MetLife, Inc., as an entity at 16.1% of the class (102,098,469 shares), filed 2026-08-06 for an event on 2026-08-06.
What did MET report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) MetLife reported revenue of $724.0M, up 19.9% from the same quarter a year earlier, and net income of $736.0M (1.09 diluted EPS). In FY 2025 it generated $17.09B of operating cash flow and spent $2.88B on buybacks and $1.51B on dividends.
Which tracked 13F managers own MET?
7 of the 30 tracked 13F managers held MET shares at their latest filing, $511.7M in all. The largest: Cliff Asness's AQR Capital Management (4.1M shares, $348.8M), Ken Griffin's Citadel Advisors (872K shares, $73.8M), Ray Dalio's Bridgewater Associates (622K shares, $52.6M), Izzy Englander's Millennium Management (188K shares, $15.9M), D. E. Shaw & Co. (184K shares, $15.6M), Two Sigma Investments (54K shares, $4.5M). The table above lists all 7.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.